Introduction: Obesity is associated with chronic inflammation. Chronic inflammation has also been linked to insulin resistance and type 2 diabetes, metabolic associated fatty liver disease, and cardiovascular disease. Glucagon-like peptide-1 (GLP-1) receptor analogs (GLP-1RA) are clinically used to treat obesity, with known anti-inflammatory properties. How the GLP-1RA exenatide effects inflammation in adolescents with obesity is not fully investigated. Methods: Forty-four patients were randomized to receive weekly subcutaneous injections with either 2 mg exenatide or placebo for 6 months. Plasma samples were collected at baseline and at the end of the study, and 92 inflammatory proteins were measured. Results: Following treatment with exenatide, 15 out of the 92 proteins were decreased, and one was increased. However, after adjustment for multiple testing, only IL-18Rα was significantly lowered following treatment. Conclusions: Weekly injections with 2 mg of exenatide lowers circulating IL-18Rα in adolescents with obesity, which may be a potential link between exenatide and its anti-inflammatory effect in vivo. This contributes to exenatide’s pharmaceutical potential as a treatment for obesity beyond weight control and glucose tolerance, and should be further studied mechanistically.

1.
Trøseid
M
,
Seljeflot
I
,
Arnesen
H
.
The role of interleukin-18 in the metabolic syndrome
.
Cardiovasc Diabetol
.
2010
;
9
:
11
.
2.
Manell
H
,
Staaf
J
,
Manukyan
L
,
Kristinsson
H
,
Cen
J
,
Stenlid
R
.
Altered plasma levels of glucagon, GLP-1 and glicentin during OGTT in adolescents with obesity and type 2 diabetes
.
J Clin Endocrinol Metab
.
2016
;
101
(
3
):
1181
9
.
3.
Flisiak-Jackiewicz
M
,
Bobrus-Chociej
A
,
Tarasów
E
,
Wojtkowska
M
,
Białokoz-Kalinowska
I
,
Lebensztejn
DM
.
Predictive role of interleukin-18 in liver steatosis in obese children
.
Can J Gastroenterol Hepatol
.
2018
;
2018
:
3870454
.
4.
Van Guilder
GP
,
Hoetzer
GL
,
Greiner
JJ
,
Stauffer
BL
,
Desouza
CA
.
Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults
.
Obesity
.
2006
;
14
(
12
):
2127
31
.
5.
Lamers
D
,
Famulla
S
,
Wronkowitz
N
,
Hartwig
S
,
Lehr
S
,
Ouwens
DM
.
Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome
.
Diabetes
.
2011
;
60
(
7
):
1917
25
.
6.
Stenlid
R
,
Manell
H
,
Halldin
M
,
Kullberg
J
,
Ahlström
H
,
Manukyan
L
.
High DPP-4 concentrations in adolescents are associated with low intact GLP-1
.
J Clin Endocrinol Metab
.
2018
;
103
(
8
):
2958
66
.
7.
Weghuber
D
,
Forslund
A
,
Ahlström
H
,
Alderborn
A
,
Bergström
K
,
Brunner
S
.
A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesity
.
Pediatr Obes
.
2020
;
15
(
7
):
e12624
.
8.
Lee
YS
,
Jun
HS
.
Anti-inflammatory effects of GLP-1-based therapies beyond glucose control
.
Mediators Inflamm
.
2016
;
2016
:
3094642
.
9.
Izaguirre
M
,
Gómez-Ambrosi
J
,
Rodríguez
A
,
Ramírez
B
,
Becerril
S
,
Valentí
V
.
GLP-1 limits adipocyte inflammation and its low circulating pre-operative concentrations predict worse type 2 diabetes remission after bariatric surgery in obese patients
.
J Clin Med
.
2019
;
8
(
4
):
479
.
10.
Wik
L
,
Nordberg
N
,
Broberg
J
,
Björkesten
J
,
Assarsson
E
,
Henriksson
S
.
Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis
.
Mol Cell Proteomics
.
2021
;
20
:
100168
.
11.
Manell
H
,
Shen
Q
,
Chowdhury
A
,
Roomp
K
,
Ciba
I
,
Weghuber
D
.
Biomarker screening in children and adolescents reveals that CUB domain-containing protein 1 is associated with obesity and that hepatocyte growth factor is associated with weight gain
.
Obes Med
.
2023 May 1
39
100481
.
12.
Tsutsumi
N
,
Kimura
T
,
Arita
K
,
Ariyoshi
M
,
Ohnishi
H
,
Yamamoto
T
.
The structural basis for receptor recognition of human interleukin-18
.
Nat Commun
.
2014
;
5
(
1
):
5340
.
13.
Kaplanski
G
.
Interleukin-18: biological properties and role in disease pathogenesis
.
Immunol Rev
.
2018
;
281
(
1
):
138
53
.
14.
Siegmund
B
,
Lehr
HA
,
Fantuzzi
G
,
Dinarello
CA
.
IL-1β-converting enzyme (caspase-1) in intestinal inflammation
.
Proc Natl Acad Sci U S A
.
2001
;
98
(
23
):
13249
54
.
15.
Dinarello
C
,
Novick
D
,
Kim
S
,
Kaplanski
G
.
Interleukin-18 and IL-18 binding protein
.
Front Immunol
.
2013
;
4
:
289
.
16.
Reznikov
LL
,
Kim
SH
,
Zhou
L
,
Bufler
P
,
Goncharov
I
,
Tsang
M
.
The combination of soluble IL-18Ralpha and IL-18Rbeta chains inhibits IL-18-induced IFN-gamma
.
J Interferon Cytokine Res
.
2002
;
22
(
5
):
593
601
.
17.
Harms
RZ
,
Yarde
DN
,
Guinn
Z
,
Lorenzo-Arteaga
KM
,
Corley
KP
,
Cabrera
MS
.
Increased expression of IL-18 in the serum and islets of type 1 diabetics
.
Mol Immunol
.
2015
;
64
(
2
):
306
12
.
18.
Rothe
H
,
Jenkins
NA
,
Copeland
NG
,
Kolb
H
.
Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2
.
J Clin Invest
.
1997
;
99
(
3
):
469
74
.
19.
Lewis
EC
,
Dinarello
CA
.
Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor
.
Proc Natl Acad Sci U S A
.
2006
;
103
(
45
):
16852
7
.
20.
Frigerio
S
,
Holländer
GA
,
Zumsteg
U
.
Functional IL-18 Is produced by primary pancreatic mouse islets and NIT-1 beta cells and participates in the progression towards destructive insulitis
.
Horm Res
.
2002
57
3–4
94
104
.
21.
Zaccone
P
,
Phillips
J
,
Conget
I
,
Cooke
A
,
Nicoletti
F
.
IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse
.
Clin Immunol
.
2005
;
115
(
1
):
74
9
.
22.
Dong
GP
,
Yu
ZS
,
Liang
L
,
Zou
CC
,
Fu
JF
,
Wang
CL
.
IL-18 gene promoter -137C/G and -607C/A polymorphisms in Chinese Han children with type 1 diabetes mellitus
.
Int J Immunogenet
.
2007
;
34
(
2
):
75
9
.
23.
Thorand
B
,
Kolb
H
,
Baumert
J
,
Koenig
W
,
Chambless
L
,
Meisinger
C
.
Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984–2002
.
Diabetes
.
2005
;
54
(
10
):
2932
8
.
24.
Bruun
JM
,
Stallknecht
B
,
Helge
JW
,
Richelsen
B
.
Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss
.
Eur J Endocrinol
.
2007
;
157
(
4
):
465
71
.
25.
Jung
C
,
Gerdes
N
,
Fritzenwanger
M
,
Figulla
HR
.
Circulating levels of interleukin-1 family cytokines in overweight adolescents
.
Mediators Inflamm
.
2010
;
2010
:
958403
.
You do not currently have access to this content.